Daito Pharmaceutical ,Ltd. Current Assets

Daito Pharmaceutical ,Ltd. posts a current assets of $37B as of May 2026. That compares with $42B in the prior-year period — down 12.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Daito Pharmaceutical ,Ltd.'s current assets was $42B. The latest reading is $37B — a 12.2% year-over-year decrease (period ending May 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Daito Pharmaceutical ,Ltd.'s financial statement story. At $37B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4577.T's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Daito Pharmaceutical ,Ltd.'s other metric pages and overview cover the third.